Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.

N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives were designed and synthesized as potential noncompetitive AMPA receptor antagonists on the basis of molecular modeling studies. Sound-induced seizure testing showed that this class of compounds possessed anticonvulsant properties. In particular, 10c was more potent than talampanel (2), a noncompetitive AMPA receptor antagonist currently being investigated in phase III trials as an antiepileptic agent. Furthermore, electrophysiological studies indicated that 10c was a highly effective noncompetitive-type modulator of the AMPA receptor.

[1]  A. Ganong,et al.  Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist , 2002, Neuropharmacology.

[2]  G. De Sarro,et al.  Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones. , 2000, Journal of medicinal chemistry.

[3]  M. Baraldi,et al.  Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones. , 2000, Journal of medicinal chemistry.

[4]  R. Gitto,et al.  AMPA receptor antagonists , 1999 .

[5]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[6]  C. Valenzuela,et al.  Allosteric modulators of the AMPA receptor: novel 6-substituted dihydrophthalazines. , 1999, Bioorganic & Medicinal Chemistry Letters.

[7]  A. Constanti,et al.  3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists. , 1998, Journal of medicinal chemistry.

[8]  P. Kadaba,et al.  Molecular targets for the rational design of antiepileptic drugs and related neuroprotective agents , 1997 .

[9]  A. Constanti,et al.  1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. , 1997, Journal of medicinal chemistry.

[10]  M. O'Neill,et al.  Stereoselective Effects of 2,3-benzodiazepines In Vivo: Electrophysiology and Neuroprotection Studies , 1996, Neuropharmacology.

[11]  K. A. Jones,et al.  Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. , 1996, Journal of medicinal chemistry.

[12]  G. De Sarro,et al.  GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice. , 1995, European journal of pharmacology.

[13]  M. Rogawski,et al.  Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity. , 1994, The Journal of pharmacology and experimental therapeutics.

[14]  A. Constanti,et al.  Persistent muscarinic excitation in guinea-pig olfactory cortex neurons: Involvement of a slow post-stimulus afterdepolarizing current , 1993, Neuroscience.

[15]  M. Rogawski,et al.  GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses , 1993, Neuron.

[16]  A. P. Venkov,et al.  A NEW METHOD FOR SYNTHESIZING 2-ACYL-1-ARYL-1,2,3,4-TETRAHYDROISOQUINOLINES , 1978 .

[17]  F. Wilcoxon,et al.  A simplified method of evaluating dose-effect experiments. , 1948, The Journal of pharmacology and experimental therapeutics.

[18]  K. Shudo,et al.  Prototype Pictet−Spengler Reactions Catalyzed by Superacids. Involvement of Dicationic Superelectrophiles , 1999 .

[19]  M. Rogawski,et al.  AMPA receptors in epilepsy and as targets for antiepileptic drugs. , 1999, Advances in neurology.

[20]  B. Meldrum,et al.  Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. , 1984, Arzneimittel-Forschung.